Search - tctmd.com

Displaying 1 - 3 of 3

Sort: Relevancy | Date

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

May 22, 2018

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

News Daily News

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

February 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.